JNCCN 360

By: Anna Nowogrodzki Posted: Wednesday, July 15, 2020 Relative survival increased significantly between 1989 and 2017 among patients in the Netherlands with chronic myeloid leukemia (CML) aged 70 and older, likely because of increased use of tyrosine kinase inhibitors (TKIs), according to a recent…

Read the full article here

Source: jnccn360.org
Categories: Hem/Onc News and Journals, Latest Headlines
Tags: , ,
Tweets with this article
Journal of the @NCCN
Trends in primary treatment and survival among elderly patients with #CML from 1989 to 2017: https://t.co/3orAMUT5Ka #leusm #JNCCN360 https://t.co/RJBwOCtLbd

Related Articles